HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.
published in: Journal of Translational Medicine
date of publication: 2012-01-12
main subject: chemotherapy
Cites articles 73
Date
Title
Article - wd:Q35744973